Clinical Trial Update: An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

An exploratory Phase 4 study assessing ganglioside GM1 in acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• GM1 ganglioside (GM1 ganglioside)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Stroke, Ischemic | Phase 4 | Status: COMPLETED